Our Organisation
EUPATI operates as a public-private partnership, and our governance structure embodies this collaborative spirit. In addition to our dedicated Secretariat, all partners and members of the EUPATI National Platform Network generously contribute their time, underscoring our collective commitment. The organisational map below illustrates our current structure, which is designed to adapt and expand as we continue to evolve and grow. This dynamic framework allows us to respond effectively to new challenges and opportunities, ensuring that our governance remains aligned with our mission and goals.
Our Structure
The EUPATI Secretariat
The EUPATI Secretariat supports the day-to-day running of the EUPATI Foundation. supporting the committees and working closely with the EUPATI governance and the Sustaining Partners Assembly (SPA) to ensure the EUPATI Foundation works to achieve its mission of enhancing patient involvement through education.
Meet the Team
Board of Trustees
The Board of Trustees of the ‘Stichting’ EUPATI Foundation:
- Jytte Lyngvig, Denmark (Chair) – Senior consultant, previously the Senior Vice President and Managing Director for DIA Europe, Executive Director for the Danish Medicines Agency, Vice-Chair and Member of the EMA Management Board
- Ivett Jakab, Hungary (Vice-Chair)- Reseach Project Manager at YAGHMA, Patient advocate and health economist, former President of the European Patients’ Forum (EPF) Youth Group
- Denis Groot, Netherlands (Treasurer) – Finance Director of Foundation Lygature, a public-private partnership management organization
- Richard Bergström, Sweden – Vice President European Affairs at IQVIA, previously Covid-19 Vaccine Coordinator for the Government of Sweden, former Director General of EFPIA
- Matthias Gottwald, Germany – Independent consultant, previously Head of R&D Policy and Networking at Bayer
EUPATI Board
The EUPATI Board sets the overall strategy and takes all major strategic decisions on the direction of EUPATI. It is chaired by a patient representative proposed by the European Patients’ Forum (EPF) and co-chaired by an industry representative nominated by the industry stakeholder cluster.
The EUPATI Board is currently led by Anders Olauson from the European Patients’ Forum (EPF) as the Chair and Kay Warner from GlaxoSmithKline (GSK) as the Co-Chair. Both Anders and Kay have a long track-record in patient engagement and patient education and have contributed to EUPATI since the start.
In addition, each of the following stakeholder groups, as represented in the 4 clusters in the Sustaining Partners Assembly, can nominate 2 persons to represent them on the EUPATI Board:
– Chair: Anders Olauson (EPF)
– Co-chair: Kay Warner (GSK)
– 2 Patient Representatives: Paul Clift (EATG) and Amelia Hursey (Parkinson’s Europe)
– 2 Academic / NGO Representatives: Christine Kubiak (ECRIN) and Begonya Nafria Escalera (Sant Joan de Deu)
– 2 Industry Representatives: Donatella Decise (Sobi) and Daniel De Schryver (Johnson & Johnson Innovative Medicine)
– 2 National Platform Representatives: Sandrine Lavallé (EUPATI Luxembourg) and Jozef Glasa (EUPATI Slovakia)
Sustaining Partners Assembly
The EUPATI Sustaining Partners Assembly (SPA) consists of all EUPATI Partners committed to supporting EUPATI through in-cash or in-kind contribution. Sustaining Partners set the strategic objectives of EUPATI.
The SPA is chaired by the EUPATI Board Chair and Co-Chair and is organised in four clusters of stakeholder groups:
– Patient organisations
– Industry
– Academia & NGOs
– National Platforms
Each cluster elects representatives to the EUPATI Board which oversees the implementation of the strategic direction of EUPATI.
EUPATI invites new members of all the different clusters to join the EUPATI, please contact us for more information!
EUPATI National Platforms Network (ENPs)
The National Platforms Network (ENPs) consists of representatives of each of the EUPATI National Platforms (currently 24). Each National Platform elects one individual to the so-called ENP SPA Cluster, who then select two individuals to represent ENPs in the EUPATI Board. For more information on ENPs, please see here.
EUPATI Secretariat
The EUPATI Secretariat implements the decisions of the EUPATI Board, the annual work plan and is responsible for the day-to-day operations of EUPATI. It is led by the Executive Director.
The team consists of:
- Executive Director
- Partnerships & Operations Coordinator
- Training Organisation & Alumni Coordinator
- Content Development Coordinator
- Business Development Coordinator
- Networks and Communications Coordinator
- IT Coordinator
- Open Classroom Coordinator
- Project Coordinator (SIMPATHIC, GEREMY and COMBINE)
- Project Coordinator (HTA4Patients)
- Project Assistant
- Intern(s)
Editorial Board
The EUPATI Editorial Board consists of 5 members representing all stakeholders. The Editorial Board reviews all new or updated content for EUPATI Toolbox and Patient Expert Course (including all related e-Learning and Face2Face course content). They guarantee that EUPATI content is well-focused, consistent, understandable, accessible and targeted. They also advice the EUPATI Secretariat about any content that needs to be updated, e.g. due to regulatory changes. The Editorial Board signs off on all EUPATI content before it is released to the public.
The members of the Editorial Board as of October 2020 are as follows:
- Jana Popova EUPATI Secretariat, Coordinator
- Magdalena Ankiersztejn-Bartczak, EATG
- Birka Lehmann, Federal Institute for Drugs and Medical Devices, Germany (BfArM)
- Wolf See, Ruhr University of Bochum
- Léa-Isabelle Proulx, Roche
The Terms of References for the Editorial Board are available to download here.
Advisory Committee
The EUPATI Advisory Committee was active during the IMI-project period until 2017, and was re-initiated in 2021. It provides advice to the EUPATI Board of Trustees, the EUPATI Board and the Secretariat on issues pertaining to regulatory, HTA, ethics and other domains. It is composed of high-level representatives with long standing experience and credibility in medicines regulation, including policies covering information to patients’ and guidance on working with patients. The current members are listed below:
- Chairperson: David Haerry, Patvocates/EATG
- Co-Chairperson: Wolf See, Ruhr University Bochum
Regulatory arm:
- Birka Lehmann, ex BfArM – Lead
- Gabriela Zenhäusern, Swissmedic
- Heather Rogers, MHRA
- Mike Dykes, MHRA
- Fokaline Vroom, MEB
- Leon Bongers, MEB
- Roelie Marinus, MEN
- Katharina Prenner, AGES
- Sinead Curran, HPRA
HTA arm:
- Neil Bertelsen, independent – Lead
- Karen Facey, independent
Ethics arm:
- Ingrid Klingmann, EFGCP – Lead
The Terms of References for the Advisory Committee are available to download here.
Patient Expert Training Committee
Members of the multi-stakeholder EUPATI Patient Expert Training Committee contribute to the conception, development, and implementation of in-person and live streaming events linked EUPATI Patient Expert Training Programme. The composition of the committee changes regularly. The current members (2024) are listed below:
- Chair: Ingrid Klingmann, European Forum for Good Clinical Practice (EFGCP)
- Co-Chair: Ingrid Heyne, EUPATI Training Organisation and Alumni Coordinator
- Vasiliki – Rafaela Vakouftsi, EUPATI Fellow
- Barry McGrath, EUPATI Fellow
- Menia Koukougianni, EUPATI Fellow
- Nathalie Deldime, EUPATI Fellow
- Cristin Lind, ENP Sweden
- Bruno Gago, University of Aveiro, ENP Portugal
- Birka Lehmann, Senior Expert Drug Regulatory Affairs, lecturer University of Bonn
- Victoria Siegrist, Roche
- Wafae Iraqi, Janssen
- Donatella Decise, Sobi
- Sylvia Herget, CSLBerhing
- Tamás Bereczky, EATG
- Lenka Souckova, Ecrin
- Jana Popova, EUPATI Patient Engagement Training Coordinator
- Maria Dutarte, EUPATI Executive Director
- Laia Bisbal, EUPATI Open Classroom Coordinator
The Terms of References for the Patient Expert Training Committee are available to download here.
Collaboration with the EUPATI Family
In addition to the EUPATI Governance, the EUPATI Foundation interacts with a wider ‘EUPATI Family’. Namely our committed formal partners of the organisation, the alumni of EUPATI Fellows, our National Platforms and the ‘EUPATI Collaborators’ – a wider network of organisations and individuals that we frequently engage and collaborate with. By maintaining these partnerships, EUPATI can continue to advance its mission for global patient involvement through a diverse and holistic approach.